NEO logo

NeoGenomics (NEO) Revenue

Annual Revenue

$591.64 M
+$81.92 M+16.07%

December 31, 2023

Summary

Performance

1-Year Change

+16.07%

3-Year Change

+33.12%

5-Year Change

+113.79%

15-Year Change

+146.26%

NEO Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.52%
NEO annual revenue is higher than 76.52% of companies in Healthcare sector

Analysts Estimate

$661.96 M
NEO annual revenue is currently -10.62% lower than the consensus analysts' forecast

High & Low

All-time High

$591.64 M
NEO annual revenue is currently at an all-time high

3-Year Low

$484.33 M
NEO annual revenue is currently +22.16% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NEO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 18, 2025
NEO next annual earnings announcement is scheduled for Feb 18, 2025

OtherNEOprofitabilitymetrics:

Annual EPS

-$0.70
NEO annual earnings per share is -$0.70

Annual Net Income

-$87.97 M
NEO annual net profit is -$87.97 million

Annual Operating Profit

-$96.65 M
NEO annual operating income is -$96.65 million

Annual Gross Profit

$244.60 M
NEO annual gross profit is $244.60 million

Quarterly Revenue

$167.82 M
+$3.32 M+2.02%

September 30, 2024

Summary

Performance

3-Month Change

+2.02%

1-Year Change

+7.89%

3-Year Change

+38.31%

5-Year Change

+60.33%

NEO Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.12%
NEO quarterly revenue is higher than 74.12% of companies in Healthcare sector

Analysts Estimate

$173.40 M
NEO quarterly revenue is currently -3.22% lower than the consensus analysts' forecast

High & Low

All-time High

$167.82 M
NEO quarterly revenue is currently at an all-time high

3-Year Low

$117.17 M
NEO quarterly revenue is currently +43.23% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 18, 2025
NEO next earnings announcement is scheduled for Feb 18, 2025

Related metrics

Quarterly Gross Profit

$74.88 M
NEO quarterly gross profit is $74.88 million

Quarterly Operating Profit

-$20.19 M
NEO quarterly operating income is -$20.19 million

Quarterly Net Income

-$17.70 M
NEO quarterly net profit is -$17.70 million

Quarterly EPS

-$0.14
NEO quarterly earnings per share is -$0.14

TTM Revenue

$644.12 M
+$15.87 M+2.53%

September 30, 2024

Summary

Performance

3-Month Change

+2.53%

1-Year Change

+8.87%

3-Year Change

+32.92%

5-Year Change

+57.55%

NEO TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74%
NEO TTM revenue is higher than 74% of companies in Healthcare sector

Analysts Estimate

$661.96 M
NEO TTM revenue is currently -2.70% lower than the consensus analysts' forecast

High & Low

All-time High

$644.12 M
NEO TTM revenue is currently at an all-time high

3-Year Low

$484.33 M
NEO TTM revenue is currently +32.99% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 18, 2025
NEO next earnings announcement is scheduled for Feb 18, 2025

OtherNEOprofitabilitymetrics:

TTM Gross Profit

$280.43 M
NEO TTM gross profit is $280.43 million

TTM Operating Profit

-$86.12 M
NEO TTM operating income is -$86.12 million

TTM Net Income

-$77.73 M
NEO TTM net profit is -$77.73 million

TTM EPS

-$0.61
NEO TTM earnings per share is -$0.61

NEO Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.1%+7.9%+8.9%
3 y3 years+33.1%+38.3%+32.9%
5 y5 years+113.8%+60.3%+57.5%

NEO Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+22.2%at high+43.2%at high+33.0%
5 y5-yearat high+44.7%at high+93.0%at high+59.2%
alltimeall timeat high>+9999.0%at high-100.0%at high-100.0%

NeoGenomics Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$167.82 M(+2.0%)
$644.12 M(+2.5%)
Jun 2024
-
$164.50 M(+5.3%)
$628.25 M(+2.9%)
Mar 2024
-
$156.24 M(+0.4%)
$610.66 M(+3.2%)
Dec 2023
$591.64 M(+16.1%)
$155.55 M(+2.4%)
$591.64 M(+2.9%)
Sep 2023
-
$151.95 M(+3.4%)
$574.80 M(+4.2%)
Jun 2023
-
$146.92 M(+7.1%)
$551.62 M(+4.1%)
Mar 2023
-
$137.22 M(-1.1%)
$529.78 M(+3.9%)
Dec 2022
$509.73 M(+5.2%)
$138.71 M(+7.7%)
$509.73 M(+2.6%)
Sep 2022
-
$128.78 M(+3.0%)
$496.75 M(+1.5%)
Jun 2022
-
$125.07 M(+6.7%)
$489.31 M(+0.7%)
Mar 2022
-
$117.17 M(-6.8%)
$485.96 M(+0.3%)
Dec 2021
$484.33 M(+9.0%)
$125.73 M(+3.6%)
$484.33 M(-0.1%)
Sep 2021
-
$121.34 M(-0.3%)
$484.59 M(-0.8%)
Jun 2021
-
$121.72 M(+5.4%)
$488.70 M(+7.7%)
Mar 2021
-
$115.53 M(-8.3%)
$453.95 M(+2.1%)
Dec 2020
$444.45 M(+8.7%)
$126.00 M(+0.4%)
$444.45 M(+4.5%)
Sep 2020
-
$125.44 M(+44.2%)
$425.32 M(+5.1%)
Jun 2020
-
$86.98 M(-18.0%)
$404.55 M(-3.5%)
Mar 2020
-
$106.03 M(-0.8%)
$419.28 M(+2.6%)
Dec 2019
$408.83 M(+47.7%)
$106.87 M(+2.1%)
$408.83 M(+8.0%)
Sep 2019
-
$104.67 M(+2.9%)
$378.44 M(+10.4%)
Jun 2019
-
$101.71 M(+6.4%)
$342.86 M(+11.0%)
Mar 2019
-
$95.58 M(+25.0%)
$308.89 M(+11.6%)
Dec 2018
$276.74 M(+15.2%)
$76.47 M(+10.7%)
$276.74 M(+5.8%)
Sep 2018
-
$69.10 M(+2.0%)
$261.69 M(+4.0%)
Jun 2018
-
$67.75 M(+6.8%)
$251.73 M(+2.2%)
Mar 2018
-
$63.42 M(+3.3%)
$246.25 M(+2.5%)
Dec 2017
$240.25 M(+3.6%)
$61.42 M(+3.9%)
$240.25 M(+5.8%)
Sep 2017
-
$59.14 M(-5.0%)
$227.04 M(-0.7%)
Jun 2017
-
$62.26 M(+8.4%)
$228.67 M(-0.4%)
Mar 2017
-
$57.43 M(+19.1%)
$229.53 M(-1.0%)
Dec 2016
$231.81 M(+132.3%)
$48.22 M(-20.6%)
$231.81 M(+9.9%)
Sep 2016
-
$60.76 M(-3.8%)
$210.87 M(+20.3%)
Jun 2016
-
$63.13 M(+5.7%)
$175.24 M(+28.4%)
Mar 2016
-
$59.70 M(+118.9%)
$136.48 M(+36.8%)
Dec 2015
$99.80 M(+14.6%)
$27.28 M(+8.6%)
$99.80 M(+2.3%)
Sep 2015
-
$25.13 M(+3.1%)
$97.52 M(+2.0%)
Jun 2015
-
$24.37 M(+5.8%)
$95.61 M(+4.0%)
Mar 2015
-
$23.03 M(-7.9%)
$91.91 M(+5.6%)
Dec 2014
$87.07 M(+31.0%)
$25.00 M(+7.7%)
$87.07 M(+8.3%)
Sep 2014
-
$23.22 M(+12.3%)
$80.39 M(+8.6%)
Jun 2014
-
$20.67 M(+13.7%)
$74.06 M(+7.3%)
Mar 2014
-
$18.18 M(-0.8%)
$68.99 M(+3.8%)
Dec 2013
$66.47 M(+11.0%)
$18.32 M(+8.5%)
$66.47 M(+5.4%)
Sep 2013
-
$16.88 M(+8.2%)
$63.04 M(+4.4%)
Jun 2013
-
$15.60 M(-0.3%)
$60.36 M(-0.0%)
Mar 2013
-
$15.66 M(+5.1%)
$60.36 M(+0.8%)
Dec 2012
$59.87 M
$14.89 M(+4.9%)
$59.87 M(+3.5%)
Sep 2012
-
$14.20 M(-9.0%)
$57.87 M(+5.2%)
DateAnnualQuarterlyTTM
Jun 2012
-
$15.61 M(+3.0%)
$54.98 M(+10.3%)
Mar 2012
-
$15.16 M(+17.6%)
$49.84 M(+14.6%)
Dec 2011
$43.48 M(+26.5%)
$12.89 M(+13.9%)
$43.48 M(+10.5%)
Sep 2011
-
$11.32 M(+8.2%)
$39.35 M(+7.1%)
Jun 2011
-
$10.47 M(+18.9%)
$36.73 M(+5.7%)
Mar 2011
-
$8.80 M(+0.6%)
$34.76 M(+1.1%)
Dec 2010
$34.37 M(+16.6%)
$8.76 M(+0.5%)
$34.37 M(+2.9%)
Sep 2010
-
$8.71 M(+2.6%)
$33.41 M(+4.4%)
Jun 2010
-
$8.49 M(+0.9%)
$32.00 M(+3.3%)
Mar 2010
-
$8.42 M(+7.9%)
$30.97 M(+5.1%)
Dec 2009
$29.47 M(+47.2%)
$7.80 M(+6.9%)
$29.47 M(+6.8%)
Sep 2009
-
$7.30 M(-2.2%)
$27.59 M(+8.9%)
Jun 2009
-
$7.46 M(+7.9%)
$25.34 M(+11.3%)
Mar 2009
-
$6.91 M(+16.8%)
$22.77 M(+13.7%)
Dec 2008
$20.02 M(+74.0%)
$5.92 M(+17.2%)
$20.02 M(+11.9%)
Sep 2008
-
$5.05 M(+3.5%)
$17.89 M(+12.1%)
Jun 2008
-
$4.88 M(+17.3%)
$15.96 M(+18.9%)
Mar 2008
-
$4.16 M(+9.7%)
$13.42 M(+16.7%)
Dec 2007
$11.50 M(+77.7%)
$3.80 M(+21.5%)
$11.50 M(+21.5%)
Sep 2007
-
$3.12 M(+33.2%)
$9.47 M(+19.1%)
Jun 2007
-
$2.34 M(+4.5%)
$7.95 M(+7.8%)
Mar 2007
-
$2.24 M(+27.2%)
$7.37 M(+13.9%)
Dec 2006
$6.48 M(+243.5%)
$1.76 M(+10.0%)
$6.48 M(+18.5%)
Sep 2006
-
$1.60 M(-9.4%)
$5.46 M(+23.6%)
Jun 2006
-
$1.77 M(+31.5%)
$4.42 M(+47.4%)
Mar 2006
-
$1.34 M(+79.0%)
$3.00 M(+59.1%)
Dec 2005
$1.89 M(+237.8%)
$750.90 K(+34.3%)
$1.89 M(+48.4%)
Sep 2005
-
$559.30 K(+62.2%)
$1.27 M(+52.5%)
Jun 2005
-
$344.90 K(+49.8%)
$832.80 K(+36.7%)
Mar 2005
-
$230.20 K(+69.5%)
$609.40 K(+9.2%)
Dec 2004
$558.10 K(+50.8%)
$135.80 K(+11.4%)
$558.10 K(-0.1%)
Sep 2004
-
$121.90 K(+0.3%)
$558.90 K(+6.0%)
Jun 2004
-
$121.50 K(-32.1%)
$527.20 K(+10.1%)
Mar 2004
-
$178.90 K(+31.0%)
$478.70 K(+29.4%)
Dec 2003
$370.00 K(+295.7%)
$136.60 K(+51.4%)
$370.00 K(+27.4%)
Sep 2003
-
$90.20 K(+23.6%)
$290.50 K(+27.3%)
Jun 2003
-
$73.00 K(+4.0%)
$228.20 K(+39.4%)
Mar 2003
-
$70.20 K(+22.9%)
$163.70 K(+75.1%)
Dec 2002
$93.50 K(+9250.0%)
$57.10 K(+104.7%)
$93.50 K(+156.9%)
Sep 2002
-
$27.90 K(+228.2%)
$36.40 K(+283.2%)
Jun 2002
-
$8500.00(+750.0%)
$9500.00(+850.0%)
Dec 2001
$1000.00(-99.6%)
-
-
Sep 2001
-
$1000.00(>+9900.0%)
$1000.00(>+9900.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2001
-
$0.00(0.0%)
$126.20 K(-50.0%)
Dec 2000
$252.40 K
-
-
Sep 2000
-
$0.00(-100.0%)
$252.40 K(0.0%)
Jun 2000
-
$126.20 K(0.0%)
$252.40 K(+100.0%)
Mar 2000
-
$126.20 K
$126.20 K

FAQ

  • What is NeoGenomics annual revenue?
  • What is the all time high annual revenue for NeoGenomics?
  • What is NeoGenomics annual revenue year-on-year change?
  • What is NeoGenomics quarterly revenue?
  • What is the all time high quarterly revenue for NeoGenomics?
  • What is NeoGenomics quarterly revenue year-on-year change?
  • What is NeoGenomics TTM revenue?
  • What is the all time high TTM revenue for NeoGenomics?
  • What is NeoGenomics TTM revenue year-on-year change?

What is NeoGenomics annual revenue?

The current annual revenue of NEO is $591.64 M

What is the all time high annual revenue for NeoGenomics?

NeoGenomics all-time high annual revenue is $591.64 M

What is NeoGenomics annual revenue year-on-year change?

Over the past year, NEO annual revenue has changed by +$81.92 M (+16.07%)

What is NeoGenomics quarterly revenue?

The current quarterly revenue of NEO is $167.82 M

What is the all time high quarterly revenue for NeoGenomics?

NeoGenomics all-time high quarterly revenue is $167.82 M

What is NeoGenomics quarterly revenue year-on-year change?

Over the past year, NEO quarterly revenue has changed by +$12.27 M (+7.89%)

What is NeoGenomics TTM revenue?

The current TTM revenue of NEO is $644.12 M

What is the all time high TTM revenue for NeoGenomics?

NeoGenomics all-time high TTM revenue is $644.12 M

What is NeoGenomics TTM revenue year-on-year change?

Over the past year, NEO TTM revenue has changed by +$52.48 M (+8.87%)